Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Peter H. Duesberg
Dept. of Molecular and Cell Biology, Stanley Hall, University of California at Berkeley, Berkeley, CA 94720, USAPeter H. Duesberg
Dept. of Molecular and Cell Biology, Stanley Hall, University of California at Berkeley, Berkeley, CA 94720, USA

Original publication
Genetica 95: 51-70, 1995

Author

  • Peter Duesberg

Publisher

  • Genetica

Topic

  • Controversy

    • AIDS Paradox

    • AIDS Epidemiology

  • Haemophilia

  • Blood Transfusions

  • Zidovudine

  • AZT

  • Viral Load

  • CD4/CD8 ratio

Publish Year

  • 1995

Content Type

  • Scientific Paper

Description

  • This is a list of scientific articles related to HIV and AIDS, hemophilia, and factor VIII concentrates. Some of the articles suggest that factor VIII concentrates, which are used to treat hemophilia, may have contributed to the development of AIDS in some patients. The articles also discuss the use of AZT, a drug used to treat HIV, and the need for further research to determine its effectiveness. Overall, the articles highlight the complexity of the relationship between HIV, AIDS, and hemophilia, and the need for continued research in this area.

Meta Tag

  • HIV infection

  • AIDS

  • Hemophilia A

  • Factor VIII

  • Immunodeficiency

  • Epidemiology

  • Zidovudine treatment

  • T4/T8-cell ratio

  • Centers for Disease Control and Prevention

  • Viral burden

  • CD4 lymphocyte count

  • Azidothymidine (AZT) treatment

Author Tag

Publisher Tag

Topic Tag

  • #Peter Duesberg

  • #Blood Transfusions

  • #Haemophilia

...

Abstract

Hemophilia-AIDS has been interpreted in terms of two hypotheses: the foreign-protein-AIDS hypothesis and the Human Immunodeficiency Virus (HIV)-AIDS hypothesis. The foreign-protein-AIDS hypothesis holds that proteins contaminating commercial clotting factor VIII cause immunosuppression. The foreign-protein hypothesis, but not the HIV hypothesis, correctly predicts seven characteristics of hemophilia-AIDS: 1) The increased life span of American hemophiliacs in the two decades before 1987, although 75% became infected by HIV-because factor VIII treatment, begun in the 1960s, extended their lives and simultaneously disseminated harmless HIV. After 1987 the life span of hemophiliacs appears to have decreased again, probably because of widespread treatment with the cytotoxic anti-HIV drug AZT. 2) The distinctly low, 1.3-2%, annual AIDS risk of hemophiliacs, compared to the higher 5-6% annual risk of intravenous drug users and male homosexual aphrodisiac drug users-because transfusion of foreign proteins is less immunosuppressive than recreational drug use. 3) The age bias of hemophilia-AIDS, i.e. that the annual AIDS risk increases 2-fold for each 10-year increase in age-because immunosuppression is a function of the lifetime dose of foreign proteins received from transfusions. 4) The restriction of hemophilia-AIDS to immunodeficiency diseases-because foreign proteins cannot cause non-immunodeficiency AIDS diseases, like Kaposi's sarcoma. 5) The absence of AIDS diseases above their normal background in sexual partners of hemophiliacs-because transfusion-mediated immunotoxicity is not contagious. 6) The occurrence of immunodeficiency in HIV-free hemophiliacs-because foreign proteins, not HIV, suppress their immune system. 7) Stabilization, even regeneration, of immunity of HIV-positive hemophiliacs by long-term treatment with pure factor VIII. This shows that neither HIV nor factor VIII plus HIV are immunosuppressive by themselves. Therefore, AIDS cannot be prevented by elimination of HIV from the blood supply and cannot be rationally treated with genotoxic antiviral drugs, like AZT. Instead, hemophilia-AIDS can be prevented and has even been reverted by treatment with pure factor VIII.

...